Shares of Live Nation Entertainment (NYSE: LYV) advanced 1.5% to $188.89 in Friday trading after California lawmakers shelved a proposed cap on ticket resale prices. The move removed a near-term regulatory overhang, though a larger federal antitrust battle continues to weigh on the company.
The California Senate Appropriations Committee declined to advance Assembly Bill 1720 on Thursday, effectively ending the California Fans First Act for this legislative session. The bill would have limited resale prices and fees to 110% of the original ticket price. However, its scope had already been narrowed to independent venues with capacities of 3,000 or fewer, exempting publicly traded operators and companies active in more than ten states. As a result, the practical impact on Live Nation was always expected to be minimal.
Live Nation had supported the bill, spending roughly $91,000 on lobbying in California this year. StubHub, a rival resale platform, spent $3.4 million in opposition. Opponents argued that the cap could inadvertently strengthen Ticketmaster by restricting alternative resale channels.
Ticketmaster's secondary ticketing operations represent only a low double-digit percentage of its gross transaction value, according to the company's public filings. Secondary sales volume in North America was unchanged in the second quarter, with the exact share not disclosed. This limited exposure helps explain why the California decision had a modest effect on the stock.
The company's core ticketing business continues to perform well. In the second quarter, ticketing generated $852.2 million in revenue, up 15% year over year, and delivered $331.0 million in adjusted operating income, a 14% increase. Ticketing now accounts for 40.5% of the company's total adjusted operating income despite representing only 11.1% of revenue.
CEO Michael Rapino highlighted that Ticketmaster sold 143 million tickets by mid-July, 14 million more than the same period last year. Deferred event revenue reached a record $6.4 billion, indicating robust demand. Fee-bearing ticket sales reached 90 million in the quarter, up 8%, while gross transaction value climbed above $10 billion, a 15% rise.
Despite these positive fundamentals, the company faces a significant federal legal challenge. In April, a federal jury ruled that Live Nation and Ticketmaster had unlawfully monopolized the U.S. ticketing market. Live Nation has set aside $450 million in the first half of the year for government probes and lawsuits.
Wall Street remains largely optimistic, though valuations suggest limited upside. Of 24 analysts monitored, 20 rate the stock a buy, with a consensus price target of $197.19, just 4.4% above Friday's close.
Risks persist, including the possibility that AB 1720 could be reintroduced in a future session. Another California bill, AB 1349, which addresses bots and speculative selling, remains eligible for a Senate vote. Federal actions could also reshape Ticketmaster's business model. Any softening in consumer demand could reduce venue occupancy and sponsorship revenue.
Friday's advance appears driven more by relief than by a fundamental re-rating. California's decision lifts one regulatory cloud, but investors continue to weigh the broader legal risks ahead.
